RSM01, a preventive treatment targeting respiratory syncytial virus (RSV), was licensed earlier this month from the Gates Medical Research Institute
Doctors highlight rising respiratory risks linked to pollution, seasonal changes, and poor treatment adherence amid increasing asthma burden in India
The aim is to simplify and strengthen long-term control of airway disease through triple therapy in one device
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
The collaboration highlights the rising importance of intranasal delivery in developing non-vaccine approaches to respiratory disease prevention
India faces a significant and growing burden of chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease
mNEXSPIKE is the third Moderna vaccine authorized in the European Union, strengthening the Company's respiratory vaccine portfolio in Europe
The decision follows an interim analysis conducted when roughly half of the patients had completed their Day 84 visit
GSK will make most of its inhaled respiratory portfolio and other products available on a direct purchasing platform, offering savings of up to 66%
_256_384.jpg)
Subscribe To Our Newsletter & Stay Updated
